In Reply II-Prescribing More Stringent Design of Randomized Clinical Trials of Omega-3 Polyunsaturated Fatty Acids
Mayo Clin Proc
.
2017 Jun;92(6):1007-1008.
doi: 10.1016/j.mayocp.2017.03.018.
Authors
James H O'Keefe
1
,
Carl J Lavie
2
Affiliations
1
Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City, Kansas City, MO.
2
John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, LA.
PMID:
28578778
DOI:
10.1016/j.mayocp.2017.03.018
No abstract available
Publication types
Letter
Comment
MeSH terms
Dietary Supplements
Fatty Acids, Omega-3*
Randomized Controlled Trials as Topic*
Substances
Fatty Acids, Omega-3